Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists

Abstract Selatogrel is a potent and reversible P2Y12 receptor antagonist developed for subcutaneous self‐administration by patients with suspected acute myocardial infarction. After single‐dose emergency treatment with selatogrel, patients are switched to long‐term treatment with oral P2Y12 receptor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Andrea Henrich (Author), Christian Hove Claussen (Author), Jasper Dingemanse (Author), Andreas Krause (Author)
Format: Knjiga
Izdano: Wiley, 2021-07-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto